Dr. Andy Hoofnagle is a researcher, professor, board certified pathologist, and laboratory director at the University of Washington. Dr. Hoofnagle’s laboratory focuses on research and development of novel biomarker assays that use mass spectrometry. Andy joins us in this episode to discuss his work in anti-doping, specifically with a focus on the development of assays to measure markers of collagen turnover for anti-doping applications.
By Partnership for Clean Competition|2021-10-19T08:30:03-06:00October 19th, 2021|Categories: Podcast|Comments Off on 64 – Developing Novel Anti-Doping Assays to Monitor Collagen Turnover – Andy Hoofnagle, MD, PhD
Dr. Annette Salmeen was a 1996 Olympian and gold medalist in swimming. In 2005, she was elected as an athlete member of the USADA Board of Directors, and she served on the board until 2012. Currently, Annette is a lecturer and Core Course Coordinator in the Human Biology Program at Stanford University, and she’s also a member of the Partnership for Clean Competition’s Scientific Advisory Board. In this episode she discusses best practices for applying for anti-doping research grants from the PCC.
Sarah Shibutse is the Director of Standards and Compliance at the Anti-Doping Agency of Kenya (ADAK). She served as a joint secretary to the Anti-Doping Task Force that was set up by the Ministry of Sports to investigate the extent of doping in Kenya. In this episode, we discuss the findings of this Task Force and the history of ADAK. Sarah shares what it was like creating a national anti-doping organization from the ground up, current challenges they are facing, their goals for the future, and more.
Dominic Mueser has worked in anti-doping for more than a decade, much of it with Germany’s national anti-doping agency. Today, he works at Sportradar, where he serves as the Global Head of Anti-Doping Services. Sportradar primarily collects and analyzes sports data, providing information to everyone from international sports federations to bookmakers. Dominic joins us in this episode to discuss Sportradar’s role in the anti-doping space and how data can be used to help ensure clean sport.
By Partnership for Clean Competition|2021-09-07T08:50:25-06:00September 7th, 2021|Categories: Podcast|Comments Off on 61 – Delivering Innovative Solutions to Fight Doping and Other Sport Integrity Issues – Dominic Mueser
JeremyLuke is Senior Director of Sport Integrity at the Canadian Center for Ethics in Sport (CCES), the Canadian national anti-doping organization (NADO). He also led the anti-doping program for the Vancouver Olympic and Paralympic Games in 2010. Jeremy joins us in this episode to talk about CCES, discuss how NADO’s have been dealing with the pandemic, and share his insights into what it takes to run anti-doping efforts during the Olympic and Paralympic Games.
Liesl Janssens is a PhD student in the Lab of Toxicology at Ghent University. Her virtual poster was a finalist in the PCC’s 2021 virtual poster session in the category of Pilot Studies. She is developing novel activity-based bioassays to screen for performance enhancing hypoxia-inducible factor (HIF) stabilizers. HIF stabilizers are small molecules that help to produce more blood cells by stimulating endogenous erythropoietin production. She shares more about this project and her work in this episode.
By Partnership for Clean Competition|2021-08-17T09:49:27-06:00August 3rd, 2021|Categories: Podcast|Comments Off on 59 – Developing New Activity-Based Bioassays to Screen for HIF Stabilizers – Liesl Janssens
Olivier Banuls served as the director for the Cycling Anti-Doping Foundation (CADF), and he is now working with the International Testing Agency (ITA) to help fight doping in cycling. He joins us in this interview to talk about the ITA and their new anti-doping efforts in the sport of cycling in collaboration with the Union Cycliste Internationale (UCI). This is the second of our two-episode mini-series taking an in-depth look at anti-doping in cycling, in conjunction with the Tour de France this month.
By Partnership for Clean Competition|2021-07-20T07:53:51-06:00July 20th, 2021|Categories: Podcast|Comments Off on 58 – Cycling Benefits from New Partnership with the International Testing Agency – Olivier Banuls
Amina Lanaya is the Director General for the Union Cycliste Internationale (UCI). She joins us in this episode to discuss UCI’s history, current anti-doping issues in cycling, UCI’s recent partnership with the International Testing Agency (ITA) to help combat doping in cycling, and more. This is the first episode of our two-part mini-series focused on anti-doping in cycling in conjunction with the ongoing Tour de France.
Dr. YaYa Yamamoto is the Senior Manager of Education & International Relations at the Japan Anti-Doping Agency (JADA). JADA has been critical in helping prepare for the Tokyo Olympic and Paralympic Games, and Dr. Yamamoto has been leading JADA’s initiatives to deliver sporting values-based and anti-doping programs. She is also a member of WADA’s education committee and the International Testing Agency (ITA) International Expert Group. We discuss JADA, the upcoming Games, and more in this episode.
Greg McKenna brings a rich background in investigation and law enforcement to his current position as Head of Biathlon Integrity Unit. In this episode, Greg discusses biathlon, doping concerns for biathletes, recent changes in the sport, development of the Biathlon Integrity Unit, and how he is applying his unique experiences to help continue to develop and refine anti-doping and integrity efforts in biathlon.
Janie Soublière is a sports lawyer and arbitrator. She’s done arbitration and legal work for everyone from the International Court of Arbitration for Sport (CAS) to the Ultimate Fighting Championship’s Anti-Doping Panel. In this episode, Janie discusses her wide array of experiences working on anti-doping cases, tribunals, and arbitration panels. She walks us through the arbitration process for anti-doping cases and shares her insights on some of the next big challenges for anti-doping law.
Jim Gagliano is the President and Chief Operating Officer of The Jockey Club, the breed registry for all thoroughbred horses in North America. He also sits on a number of councils and boards related to horse racing. In this episode, we discuss horse racing’s approach to anti-doping, current anti-doping and safety priorities, and recent changes over the past year as a result of some high-profile cases and new legislation.
Dr. Rachel Hand is a Research Fellow in Polymer Chemistry at The University of Warwick. In this episode, Dr. Hand discusses her work in the area of advancements in molecularly imprinted polymers and their role in anti-doping as well as her experiences working with the PCC on a recent research project. Plus, we talk about social media and its role in facilitating scientific collaboration in clean sport.
Phil Andrews is the Chief Executive Officer of USA Weightlifting. He has brought about significant reform to weightlifting internationally, especially in the area of anti-doping. In this episode, he discusses USA Weightlifting’s anti-doping efforts, recent controversy with the International Weightlifting Federation, implications for participation in the Olympic and Paralympic Games, and the way forward for the sport to ensure clean competition.
Howard Jacobs is an attorney and a leading advocate for athletes around the world in doping matters. He has represented more than 300 athletes in disciplinary cases related to various issues in sport. In this interview, Howard shares insights about what it’s like working in anti-doping law, walks through the steps he takes when working on an anti-doping case, and discusses experiences from some of the most memorable and prominent cases he has been involved in over the years.
Dr. Jean-Francois Naud is Deputy Director and Research Associate at the Doping Control Laboratory of the National Institute of Scientific Research (INRS) in Québec, Canada. In our interview, he discusses his work at the WADA-accredited Doping Control Laboratory, his path to becoming an anti-doping scientist, his research to improve our ability to detect blood doping, his role in anti-doping testing during the 2010 Olympic Games in Vancouver, and current challenges in anti-doping research.